This compound is a halogenated heterocyclic compound used as an intermediate in pharmaceutical manufacturing. It features a morpholine ring attached to a pyridine core substituted with bromine and chlorine atoms.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1199773-09-5
4-amino-6-tert-butyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5(2H)-one
Pharmaceutical intermediate compound
2-(2-Nitrovinyl)thiophene
Pharmaceutical intermediate compound
4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine
Pharmaceutical intermediate compound
N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
Pharmaceutical intermediate compound
(1S,5R)-8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Ol
pharmaceutical intermediate
Ethyl N-piperazinecarboxylate
pharmaceutical intermediate
4-((5,6-Dimethoxy-1-oxoindan-2-yl)methyl)piperidine hydrochloride
pharmaceutical intermediate
10-(2-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
Chelating agent intermediate for MRI contrast agents
4-(5-bromo-3-chloro-2-pyridinyl)morpholine
RIPNXWDOUNUVSM-UHFFFAOYSA-N
C1COCCN1C2=C(C=C(C=N2)Br)Cl
—